Treatment of Philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylate

Hagop M. Kantarjian*, Susan O'Brien, Jorge E. Cortes, Terry L. Smith, Mary Beth Rios, Jianqin Shan, Ying Yang, Francis J. Giles, Deborah A. Thomas, Stefan Faderl, Guillermo Garcia-Manero, Sima Jeha, William Wierda, Jean Pierre J Issa, Steven M. Kornblau, Michael Keating, Debra Resta, Renaud Capdeville, Moshe Talpaz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

103 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment of Philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylate'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

INIS